Top compounds associated with response to CTC-518B2.8


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.037 0.3
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA Imatinib CTRPv2 pan-cancer AAC -0.042 0.3
mRNA CHM-1 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.3
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.041 0.3
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.035 0.3
mRNA Ki8751 CTRPv2 pan-cancer AAC -0.041 0.3
mRNA Panobinostat CCLE pan-cancer AAC 0.045 0.3
mRNA UNC0321 CTRPv2 pan-cancer AAC -0.043 0.3
Download CSV